Lexicon Pharmaceuticals
LXRX
LXRX
133 hedge funds and large institutions have $1.1B invested in Lexicon Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 39 increasing their positions, 36 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 28
17% less call options, than puts
Call options by funds: $1.11M | Put options by funds: $1.33M
22% less capital invested
Capital invested by funds: $1.41B → $1.1B (-$309M)
Holders
133
Holding in Top 10
2
Calls
$1.11M
Puts
$1.33M
Top Buyers
| 1 | +$7.48M | |
| 2 | +$5.76M | |
| 3 | +$3.1M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$2.75M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.4M |
Top Sellers
| 1 | -$34.5M | |
| 2 | -$12.1M | |
| 3 | -$9.42M | |
| 4 |
CCI
Columbus Circle Investors
|
-$5.14M |
| 5 |
BlackRock
New York
|
-$4.7M |